USPTO Rules on Patent Term Adjustment Set to Change Following CAFC Decision
February 5, 2019
The USPTO may be forced to rethink its regulations on calculating PTA following the Court of Appeals for the Federal Circuit precedential decision in Supernus Pharmaceuticals v Iancu, write Sharon Roberg-Perez, Jake Holdreith and Jeff Hovden of Robins Kaplan LLP.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.